''Microbubbles have been the earliest and most widely used ultrasound contrast agents by virtue of their unique features: such as non-toxicity, intravenous injectability, ability to cross the pulmonary capillary bed, and significant enhancement of echo ...'

''This study aimed to determine whether the normal parotid gland (PG) and submandibular gland (SMG) can be used as reference standards for normal thyroid echogenicity. Methods In total, 1,302 consecutive patients with normal salivary glands were included ...'

''Debut at EuroEcho 2021 for AI-enhanced auto measure application helps reduce echo quantification time - Philips Healthcare expanded its cardiac ultrasound portfolio with new imaging tools and features to increase diagnostic confidence and workflow ...'

''The U.S. Food and Drug Administration (FDA) cleared software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is an accessory to compatible diagnostic ultrasound ...'

''Initial reports from the 1960s describing the observations of ultrasound contrast enhancement by tiny gaseous bubbles during echocardiographic examinations prompted the development of the first ultrasound con- trast agent in the 1980s. Current ...'

''The 129-pound, mobile system features innovative quantitative features, stress echo and TEE capabilities, delivering exceptional value to healthcare providers looking for an affordable echo system. GE has enhanced the reach of the Vivid T8 by ...'

''A recent study has demonstrated that echocardiography with a perflutren-based ultrasound contrast agent yielded a 28% lower mortality rate at 48 hours in critically ill patients compared with non-contrast echocardiography. The safety of perflutren-based ...'

''Royal Philips Electronics, a diversified health and well-being company, announced that CX50 xMATRIX, the world’s first portable ultrasound with Philips’ industry leading Live 3D TEE, now offers 2-D Intracardiac Echo (ICE) capability. The CX50 xMATRIX ...'

''Echometrix, a Madison medical technology company, has received U.S. Food and Drug Administration approval to sell its EchoSoft ultrasound technology. We're very pleased to have reached this critical milestone, said chief executive Sam Adams. The ...'

''ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE™) management device, today released the Zura EVO™ ultrasound system. This next-generation imaging platform is used with ImaCor's miniaturized, disposable ...'